{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["77(10)"],"submitter":["Watanabe M"],"funding":["GlaxoSmithKline","Grant-in-Aid for Scientific Research (KAKENHI)","Novartis Pharma","Pfizer","Environmental Restoration and Conservation Agency","Japan Society for the Promotion of Science"],"journal":["Allergy"],"pagination":["3137-3141"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9796337"],"repository":["biostudies-literature"],"pubmed_title":["Soluble ST2 enhances IL-33-induced neutrophilic and pro-type 2 inflammation in the lungs."],"pmcid":["PMC9796337"],"pubmed_authors":["Takata S","Nakamura M","Hirata A","Honda K","Ishii H","Nakamoto K","Saraya T","Aso J","Sada M","Nunokawa H","Oda M","Miyaoka C","Tamura M","Takizawa H","Chibana K","Watanabe M","Kurai D","Inui T","Yoshida Y"],"additional_accession":[]},"is_claimable":false,"name":"Soluble ST2 enhances IL-33-induced neutrophilic and pro-type 2 inflammation in the lungs.","description":null,"dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Oct","modification":"2025-04-26T00:24:19.641Z","creation":"2025-04-06T09:43:27.996Z"},"accession":"S-EPMC9796337","cross_references":{"pubmed":["35661175"],"doi":["10.1111/all.15401"]}}